{
  "component_scores": {
    "joint_involvement": {
      "score": 5,
      "justification": "10 large joints and at least 3 small joints (MCPs, PIPs, 2nd-5th MTPs) involved"
    },
    "serology": {
      "score": 2,
      "justification": "High-positive RF: >60 UI/mL (>3× ULN)"
    },
    "acute_phase": {
      "score": 1,
      "justification": "CRP abnormal: CRP value is positive and above the threshold of 10 mg/L"
    },
    "duration": {
      "score": 0,
      "justification": "No specific duration criteria mentioned"
    }
  },
  "acr_eular_total": 8,
  "treatment_context": {
    "has_dmard": true,
    "treatment_strength": "strong",
    "justification": "Presence of methotrexate (csDMARD)"
  },
  "final_label": "RA+",
  "classification_rationale": "Based on the provided facts, the patient has a total score of 8 out of 9 under ACR/EULAR criteria. The presence of high-positive RF and positive CRP indicate active inflammation. Additionally, methotrexate is a conventional synthetic DMARD (csDMARD) which provides strong evidence for RA. Therefore, the final label is 'RA+' with moderate confidence.",
  "confidence": "high",
  "patient_id": "9",
  "agent": "Agent2_v3_RAG_Guidelines",
  "rag_guidelines": {
    "query": "serology RF rheumatoid factor thresholds serology anti-CCP ACPA thresholds acute phase CRP inflammation thresholds acute phase ESR VHS inflammation thresholds joint involvement polyarthritis small joints MCPs PIPs treatment DMARD methotrexate ACR EULAR classification criteria interpretation scoring",
    "sections_retrieved": [
      "serology",
      "acute_phase_reactants",
      "joint_involvement",
      "treatment_context"
    ],
    "relevance_scores": [
      13.437418455637742,
      12.564144450970117,
      8.092676749040749,
      5.153478439892983
    ]
  },
  "guideline_citation": "Aletaha D, et al. Arthritis Rheum. 2010;62(9):2569-2581",
  "evidence_trace": [
    {
      "type": "disease_mention",
      "stay_id": "S0017",
      "line_no": 7,
      "snippet": "Diagnostic : polyarthrite rhumatoïde confirmée."
    },
    {
      "type": "disease_mention",
      "stay_id": "S0017",
      "line_no": 7,
      "snippet": "Diagnostic : polyarthrite rhumatoïde confirmée."
    },
    {
      "type": "lab",
      "test": "CRP",
      "stay_id": "S0017",
      "line_no": 3,
      "snippet": "Laboratoire (J1) : CRP 51 mg/L, VHS 85 mm/h, NFS normale."
    },
    {
      "type": "lab",
      "test": "VHS",
      "stay_id": "S0017",
      "line_no": 3,
      "snippet": "Laboratoire (J1) : CRP 51 mg/L, VHS 85 mm/h, NFS normale."
    },
    {
      "type": "lab",
      "test": "RF",
      "stay_id": "S0017",
      "line_no": 4,
      "snippet": "RF : positif (91 UI/mL)."
    },
    {
      "type": "lab",
      "test": "anti-CCP",
      "stay_id": "S0017",
      "line_no": 5,
      "snippet": "anti-CCP : négatif (<5 U/mL)."
    },
    {
      "type": "drug",
      "name": "methotrexate",
      "stay_id": "S0017",
      "line_no": 8,
      "snippet": "Prise en charge : début de méthotrexate 20 mg/semaine + acide folique 5 mg/j."
    }
  ],
  "component_scores_det": {
    "joint_involvement": 0,
    "serology": 2,
    "acute_phase": 1,
    "duration": 1
  },
  "acr_eular_total_det": 4,
  "det_label": "RA−",
  "has_dmard_det": true,
  "has_biologic_or_jak_det": false,
  "llm_vs_det_disagree": true,
  "override_applied": false
}